Webhealth Logo

A Network Connecting Healthcare Professionals
WebHealthNetwork Membership: 2,384,336

EN / ES

sign up

log in

Sign Up On Webhealth Network

Sign Up On Jobs At Webhealth Network

LogIn On Webhealth Network

LogIn On Jobs At Webhealth Network

Webhealth Logo
  • Home
  • HealthCare Directory
    • US Medical Doctor Directory
    • US Nurse Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Research Articles
  • Videos
  • Solutions
  • Jobs
    • Search For Jobs Post A Job
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Acral Lentiginous Melanoma - 12 Studies Found

Status Study
Not yet recruiting Study Name: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Condition: Acral Lentiginous Melanoma Mucosal Melanoma
Date: 2016-11-23
Interventions: Drug: Nivolumab Other Names:
Recruiting Study Name: Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
Condition: Acral Lentiginous Melanoma
Date: 2016-08-07
Interventions: Drug: pembrolizumab pembrolizumab at 200mg IV infusion every 3 weeks
Not yet recruiting Study Name: A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread
Condition: Mucosal Lentiginous Melanoma Acral Lentiginous Malignant Melanoma
Date: 2011-04-13
Interventions: Drug: nilotinib nilotinib 400 mgs orally twice daily until disease progression or withdrawal from treatm
Terminated Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
Condition: Acral Lentiginous Malignant Melanoma Lentigo Maligna Malignant
Date: 2010-05-07
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097
Terminated Study Name: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
Condition: Melanoma
Date: 2010-03-23
Interventions: Drug: Dasatinib 100 mg daily.
Active, not recruiting Study Name: Dinaciclib in Treating Patients With Stage IV Melanoma
Condition: Acral Lentiginous Melanoma Lentigo Maligna Melanoma
Date: 2009-07-10
Interventions: Drug: Dinaciclib Given IV Other Names:
Completed Study Name: Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Condition: Melanoma (Skin)
Date: 2008-06-18
Interventions: Drug: dasatinib Other: laboratory biomarke
Completed Study Name: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Condition: Mucosal Lentiginous Melanoma Acral Lentiginous Malignant Melanoma
Date: 2007-12-18
Interventions: Drug: Sunitinib Other Names: Sutent SU011248
Completed Study Name: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Condition: Acral Lentiginous Malignant Melanoma Recurrent Melanoma
Date: 2007-05-03
Interventions: Drug: imatinib mesylate Given
Recruiting Study Name: Study of Families With Melanoma
Condition: Melanoma (Skin)
Date: 2007-03-07
Interventions: Genetic: gene expression analysis Genetic:
Page 1 of 2
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy
  • Sitemap

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.